Observational studyInternational journal of molecular sciences2015

Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.

Christoph Kleinschnitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.